Otawara, Japan

Tomokazu Harada

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Kabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation, Canon Medical Systems Corporation. Active years: 2007-2024.


% Patents Active = 71.4


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • Tochigi-ken, JP (2009)
  • Irvine, CA (US) (2018)
  • Otawara, JP (2007 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Tomokazu Harada

Introduction

Tomokazu Harada is a notable inventor based in Otawara, Japan. He has made significant contributions to the field of medical imaging technology. With a total of 7 patents to his name, Harada's work has advanced the capabilities of medical diagnosis.

Latest Patents

Among his latest inventions is a medical image diagnosis apparatus. This apparatus features a gantry with a first opening for inserting a subject and a first light source that emits sterilizing light. Another significant invention is a computed tomography apparatus. This device allows for the confirmation of the positional relationship between an imaging region and a field of view in real space during imaging.

Career Highlights

Throughout his career, Harada has worked with prominent companies such as Kabushiki Kaisha Toshiba and Toshiba Medical Systems Corporation. His experience in these organizations has contributed to his expertise in medical imaging technologies.

Collaborations

Harada has collaborated with notable colleagues, including Tetsuya Sadotomo and Makoto Nakano. Their teamwork has likely played a role in the successful development of innovative medical technologies.

Conclusion

Tomokazu Harada's contributions to medical imaging through his patents and collaborations highlight his importance in the field. His inventions continue to impact medical diagnostics positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…